Form 4: Leidos Holdings Director Harry M. Jansen Kraemer Jr. Reports Stock Option Grant and Stock Deferral Plan Activity
SEC Form 4
Director Harry M. Jansen Kraemer Jr. reports acquisition of stock options and shares through a key executive stock deferral plan.
Summary
- On May 9, 2025, Harry M. Jansen Kraemer Jr., a director of Leidos Holdings, Inc., reported transactions involving Leidos common stock.
- Kraemer acquired 873 shares of common stock through a key executive stock deferral plan.
- He also acquired a stock option to buy 1,030 shares of common stock at an exercise price of $154.71, exercisable starting May 9, 2026, and expiring on May 8, 2032.
- Following these transactions, Kraemer directly owns 1,030 derivative securities and indirectly owns 127,358.0486 shares through the Key Executive Stock Deferral Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports standard transactions related to director compensation. It doesn't inherently indicate positive or negative performance.
Positives
- The acquisition of stock options and shares through the deferral plan could indicate confidence in the company's future performance from a director's perspective.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedule of the stock options suggests a multi-year commitment.
Industry Context
Stock ownership and option grants are common practices for aligning the interests of company directors with those of shareholders in publicly traded companies like Leidos.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the defense and technology industries, similar to practices at companies like Lockheed Martin, General Dynamics, and Booz Allen Hamilton.
- The vesting schedule of one year is fairly standard, aligning with typical industry practices for incentivizing long-term performance.
Stakeholder Impact
- The transactions reported may have a minor positive impact on shareholder sentiment, reflecting director alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of the reported transactions: acquisition of common stock and stock options. |
| 05/09/2026 | Date the stock option becomes exercisable. |
| 05/08/2032 | Expiration date of the stock option. |
| 05/13/2025 | Date of signature for the Form 4 filing. |
Keywords
Leidos Holdings, Director, Stock Option, Stock Deferral Plan, Beneficial Ownership, LDOS
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.